Selank and Semax for ADHD: What the Research Really Says

A recent TikTok video tagged #adhd #selank #semax #peps #biohacking implies that these two Russian nootropic peptides can improve attention and executive function in people with ADHD. The clip's casual framing—pairing the peptides with a biohacking lifestyle—may lead viewers to believe that Selank and Semax are proven cognitive enhancers for ADHD. But what does the research actually support?

What the clip claims

The video suggests that Selank and Semax, both synthetic peptides developed in Russia, can help manage ADHD symptoms like inattention and impulsivity. It implies a direct benefit for focus and mental clarity, possibly without the side effects of conventional stimulant medications.

What the research neighborhood actually covers

Selank and Semax are synthetic peptides derived from naturally occurring proteins. Selank is an analog of tuftsin, while Semax is a synthetic analog of ACTH (4-10). Both have been studied in Russia for their potential anxiolytic and nootropic effects. Research on Semax has shown some promise in improving attention and memory in animal models and small human studies, particularly in the context of stroke recovery and cognitive decline. Selank has been studied for its anxiolytic (anti-anxiety) effects, with some evidence suggesting it may also have mild cognitive benefits.

However, the specific claim that these peptides are effective for ADHD is not supported by robust clinical evidence. Most studies have been conducted in Russia, with small sample sizes and limited peer-reviewed publication in Western journals. There are no large-scale, randomized, placebo-controlled trials demonstrating that Selank or Semax can treat ADHD symptoms. The existing research is preliminary and often focuses on other conditions, such as anxiety, stroke, or age-related cognitive decline.

Limits of the evidence

The gap between the TikTok claim and the research is significant. The studies that do exist are not designed to assess ADHD as a primary outcome. They also use specific dosing and administration routes (often intranasal) that may not match what a typical biohacker would use. Furthermore, the long-term safety profile of these peptides is not well-established, and their use outside of a clinical research setting is not recommended.

Research-use caveat

For researchers, Selank and Semax are interesting compounds for studying anxiety, cognition, and neuroprotection. However, they are not approved for ADHD treatment by any major regulatory body. Any use in a research context should be strictly controlled, with clear protocols and ethical oversight. For individuals considering these peptides for self-experimentation, the evidence does not support their use as a substitute for evidence-based ADHD treatments.

Open the full video fact-check page (transcript, takeaways, embedded clip).